CIK 0001001316 · Large accelerated filer
TG THERAPEUTICS, INC.
Sign in to watch- Ticker
- TGTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 363898269
- Phone
- (212) 554-4484
- Business address
- 2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY, 10014
- Former names
- MANHATTAN PHARMACEUTICALS INC, ATLANTIC TECHNOLOGY VENTURES INC, ATLANTIC PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $274,800
- in 1 filing
Net −$274,800. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-06-16 | Charney Laurence N Director | Grant or award | +15,000 | 103,949 | ||
| 2017-06-16 | Hoberman Kenneth Director | Grant or award | +15,000 | 101,905 | ||
| 2017-06-16 | HUME DANIEL Director | Grant or award | +15,000 | 77,459 | ||
| 2017-06-16 | Echelard Yann Director | Grant or award | +15,000 | 102,068 |
Page 7 of 7 · 124 trades